Scaleup programmes

Back to programmes

Programme

IP Group

Finance and Risk Capital

Impact for scaleups

76

Companies backed

31.5%

Follow-on investments

87%

Investments outside of London

13

Growth-stage investments

Key sectors

Building & Construction Creative, digital, film, games & media Defence & security Engineering / Advanced Engineering Environmental Science & Technology Farming, fisheries & forestry Finance Food & drink Healthcare Impact ventures / Social Impact Life Sciences & Biotech Manufacturing / Advanced Manufacturing Professional services Technology & Communications Transport & Logistics

IP Group is an FTSE-250 listed IP commercialisation company whose funds provide venture capital to spin-out companies from its 17 university partnerships. The company also owns Parkwalk Advisors and stakes in Oxford Sciences Innovation and Cambridge Innovation Capital. 

IP Group invests in spin-outs from UK universities and some US universities.Cumulatively, it has formed and supported more than 300 companies and invested £850m into UK science-based businesses. Nearly nine out of ten investments made by IP Group and its subsidiary Touchstone Innovations have been into companies outside of London. 

In the period between January 2013 to June 2020, the average size of its investment round into UK companies was £8.1m. Notable UK scaleups in its portfolio include Oxford Nanopore, Inivata, Crescendo Biologics, Artios Pharma and Ieso Digital Health.

The funds invest at seed, venture and growth stages and assist companies with the commercialisation of their new products and services, with technology transfer, IP licensing and protection. The funds continue to invest in portfolio companies as they scale. The firm has a long-term partnership model with UK universities and developed an approach to supporting businesses from “cradle to maturity,” including assistance with executive search and recruitment and raising growth stage capital from co-investors.

                       

IP Group website